23 patients (66%) suffered from primary aggressive lymphoma, including two double-hit lymphomas (both with c-myc + BCL-2 translocations), one EBV positive plasmoblastic lymphoma, one primary mediastinal large B-cell lymphoma and one prolymphocytic/lymphoblastic B-CLL (Table 1). This evidence concerns the gene MYC and lymphoma.